Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DT | Common Stock | Options Exercise | $253K | +15.8K | +13.08% | $16.00 | 137K | Mar 1, 2023 | Direct | F1 |
transaction | DT | Common Stock | Sale | -$668K | -15.8K | -11.56% | $42.27 | 121K | Mar 1, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DT | Stock Option (Right to Buy) | Options Exercise | $0 | -15.8K | -33.33% | $0.00 | 31.6K | Mar 1, 2023 | Common Stock | 15.8K | $16.00 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2022 |
F2 | The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.045 to $42.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
F3 | Stock options granted on July 31, 2019, 25% of which vested on August 15, 2020, with the remainder vesting in 12 equal quarterly installments thereafter. |